Cargando…
Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention
BACKGROUND: Prostate cancer (PCa) is a common malignant human tumor and one of the main causes of cancer-related deaths in men. At present, prostate-specific antigen levels are widely used to diagnose PCa in the clinic, but they are not sufficient for an accurate early diagnosis or prognosis. METHOD...
Autores principales: | Guo, Xiaogang, Han, Tao, Hu, Pingping, Guo, Xiaojun, Zhu, Changming, Wang, Youbao, Chang, Shaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267169/ https://www.ncbi.nlm.nih.gov/pubmed/30324582 http://dx.doi.org/10.1007/s11255-018-2009-4 |
Ejemplares similares
-
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
por: Fredsøe, Jacob, et al.
Publicado: (2023) -
Expression Analysis of miRNAs and Their Potential Role as
Biomarkers for Prostate Cancer Detection
por: Bergez-Hernández, Fernando, et al.
Publicado: (2022) -
Identification of serum microRNAs as diagnostic biomarkers for schizophrenia
por: He, Kuanjun, et al.
Publicado: (2019) -
Protocol for SNOTOB study: radical prostatectomy without prostate biopsy following (18)F-PSMA-1007 PET/CT based on a diagnostic model: a single-centre, single-arm, open-label study
por: Wang, Changming, et al.
Publicado: (2023) -
Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population
por: Lyu, Ji, et al.
Publicado: (2019)